Thera4Care Theranostics Ecosystem for Personalised Care
- Coordinator
- Universita Cattolica Del Sacro Cuore, Italy
- Runs
- 1 October 2024 to 30 September 2029
- Status
- Running
- EU funding
- €14.1m
- Total cost
- €25.3m
- Partners
- 30 organisations in 15 countries
- Type
- Research and Innovation Action
- Grant agreement
- 101172788
What the project is doing
In the project's own words, from its summary on CORDIS.
Thera4Care represents a large unique consortium, gathering well-established European academic radiotheranostic centres, strong industry partners, European and medical societies focusing on training and education, a patient advocacy group spearheaded by an experienced project management group. Thera4Care aims to establish a European network of radiotheranostics centres able to rapidly develop and implement radiotheranostics tools and solutions to drive precision health.
The overarching vision of Thera4Care is to revolutionise radiotheranostics procedures by establishing, implementing, and disseminating standardised scalable methods to produce and efficiently administer key radiotheranostics solutions. Thera4Care focus is on developing diagnostic and therapeutic ligands tailored to key disease areas (such as solid tumours), aligning with the growing significance of multi-modal radiotheranostics solutions dominated by radionuclide-based therapy and companion diagnostics.
Thera4Care project is scheduled for 5 years and consists of 9 work packages. WP1 handles Project Management, WP2 focuses on Regulatory aspects, WP3 plans Preclinical studies, WP4 provides Supply chain, WP5 develops Clinical Trials, WP6 generates AI models, WP7 focuses on Dosimetry, WP8 develops Precision Imaging components, while WP9 focuses on Education and Dissemination. Thera4Care will advocate for the progress of radiotheranostics, with the goal of increasing medical knowledge and enhancing treatment efficacy for improved patient outcomes.
Concurrently, aims to coordinate scientific initiatives across European landscapes, leveraging a comprehensive and multimodal approach to cancer therapy applicable to various cancer types. Lastly, will work on the establishment of sustainable supply and production networks and the upscaling of production methodologies and supply chains across the public and private sectors, to enhance the availability of radionuclides.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Universita Cattolica Del Sacro Cuore | Milano | Italy | Coordinator |
| European Association of Nuclear Medicine | Wien | Austria | Participant |
| Association Hospitaliere De Bruxelles-Centre Hospitalier Universitaire Jules Bordet | Anderlecht | Belgium | Participant |
| Studiecentrum Voor Kernenergie / Centre D'etude De L'energie Nucleaire | Bruxelles / Brussel | Belgium | Participant |
| The Oncidium Foundation | Bruxelles | Belgium | Participant |
| Paul Scherrer Institut | Villigen Psi | Switzerland | Associatedpartner |
| Collaborate Project Management GmbH | Munchen | Germany | Participant |
| Universitaetsklinikum Essen | Essen | Germany | Participant |
| Curasight AS | Kobenhavn | Denmark | Participant |
| Minerva Imaging Aps | Olstykke | Denmark | Participant |
| Fundacion Para La Investigacion Biomedica Del Hospital Gregorio Maranon | Madrid | Spain | Third party |
| Servicio Madrileno De Salud | Madrid | Spain | Participant |
| Aiforia Technologies Oyj | Helsinki | Finland | Participant |
| Dosisoft | Cachan | France | Participant |
| Institut De Cancerologie De L'ouest | Angers | France | Participant |
| Ge Healthcare Magyarorszag Kft | Budapest | Hungary | Participant |
| Semmelweis Egyetem | Budapest | Hungary | Associatedpartner |
| Syreon Kutato Intezet Korlatolt Felelossegu Tarsasag | Budapest | Hungary | Participant |
| Ge Medical Systems Israel Ltd | Haifa | Israel | Third party |
| Datawizard SRL | Roma | Italy | Participant |
| Fondazione Policlinico Universitario Agostino Gemelli Irccs | Roma | Italy | Participant |
| Erasmus Universitair Medisch Centrum Rotterdam | Rotterdam | Netherlands | Participant |
| Terthera B.v. | Breda | Netherlands | Participant |
| Atley Solutions AB | Goteborg | Sweden | Participant |
| Exini Diagnostics AB | Lund | Sweden | Participant |
| Gems Pet Systems Aktiebolag | Uppsala | Sweden | Third party |
| Goeteborgs Universitet | Goeteborg | Sweden | Participant |
| Ge Healthcare Limited | Chalfont St Giles | United Kingdom | Associatedpartner |
| GE Healthcare IITS USA Corp. | Chicago | United States | Associatedpartner |
| Perspective Therapeutics Inc | Seattle | United States | Participant |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI